Aurobindo Pharma Ltd (AUROPHARMA) — Voting Results | 28 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
All six resolutions passed with majority shareholder approval at the 39th AGM.
🔄 What Changed
Adoption of audited standalone and consolidated financial statements for FY2026; declaration of ₹4 interim dividend; appointments of new directors and secretarial auditors.
🔮 What's Next
No forward guidance or future deadlines were provided in the filing.
💡 Investor Takeaway
Shareholders overwhelmingly endorsed the company's financials and governance decisions, signaling strong confidence in management and operations.

At the 39th AGM on August 27, 2026, shareholders approved all six resolutions with strong majorities, including adoption of standalone and consolidated financial statements, a ₹4 interim dividend, and appointments of directors and secretarial auditors. Remote e-voting and in-person polls recorded high participation, with 99.9174% in favour of financial statements and 99.9976% supporting the interim dividend. No resolution failed, and all voting thresholds were comfortably exceeded.

📄 View Original Announcement (PDF)

About Aurobindo Pharma Ltd (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹97,238.86 Cr P/E: 26.4 ROE: 9.8% ROCE: 12.8% Div Yield: 0.24%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AUROPHARMA — Free

Free account · 2 AI queries/day